Buffer Coefficient as a Predictor of the Prognosis of Massive Cerebral Infarction.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
12 2022
Historique:
received: 01 09 2022
revised: 06 10 2022
accepted: 07 10 2022
pubmed: 14 10 2022
medline: 21 12 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

To evaluate the prognostic value of the buffer coefficient, calculated as the ratio of the buffer volume (volume of intracranial cerebrospinal fluid) at the peak of brain edema to the baseline brain volume, and some other parameters in patients with massive cerebral infarction (MCI). The cohort comprised 161 patients with MCI who were divided into good and poor prognosis groups according to modified Rankin Scale score at 90 days after onset. Differences in clinical and imaging parameters between these groups were analyzed by univariate analysis, and multifactorial binary logistic regression analysis was used to further identify influencing factors that were significantly different. Receiver operating characteristic curve was used to evaluate the diagnostic performance between the buffer volume and the buffer coefficient. The findings showed that a history of atrial fibrillation, intravenous tissue-type plasminogen activator administration, successful reperfusion, successful craniectomy, low-density lesion volume, brain volume, buffer volume, and buffer coefficient were significantly different between the poor and good prognosis groups (P < 0.05 for all comparisons). Multifactorial binary logistic regression analyses revealed that patients who had large low-density lesion volume and patients who had not achieved successful reperfusion or received intravenous tissue-type plasminogen activator were likely to have a poor prognosis (P < 0.05). The buffer coefficient was identified as an independent predictive factor for MCI (P < 0.001). The area under the receiver operating characteristic curve for the buffer coefficient was 0.862. When the cutoff value was 9.3%, sensitivity of predicting poor prognosis of patients with MCI was 94.7%. The buffer coefficient has potential benefits as a prognostic indicator for MCI that can be used to detect even subtle changes in brain edema.

Identifiants

pubmed: 36228930
pii: S1878-8750(22)01429-2
doi: 10.1016/j.wneu.2022.10.023
pii:
doi:

Substances chimiques

Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e538-e545

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Qing Tan (Q)

Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China; Department of Neurology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China; NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Chongqing Medical University, Chongqing, China.

Xia Shen (X)

Department of Neurology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China; NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Chongqing Medical University, Chongqing, China.

Hongli Yang (H)

Department of Neurology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China; NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Chongqing Medical University, Chongqing, China.

Xiaoyan Xu (X)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Chongqing Medical University, Chongqing, China; Department of Pathology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.

Yujie Guo (Y)

Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China; NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Chongqing Medical University, Chongqing, China.

Juan He (J)

Department of Pathology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.

Qingjun Liu (Q)

Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Cerebrovascular Disease Research, Chongqing, China.

Xiaoyan Du (X)

Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Cerebrovascular Disease Research, Chongqing, China.

Dujun Wang (D)

Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Cerebrovascular Disease Research, Chongqing, China.

Libo Zhao (L)

Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Cerebrovascular Disease Research, Chongqing, China. Electronic address: 2267254102@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH